Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Brukinsa (zanubrutinib)
.
Show all posts
Showing posts with label
Brukinsa (zanubrutinib)
.
Show all posts
Monday, March 2, 2020
FDA Approves Brukinsa (zanubrutinib) for the Treatment of Mantle Cell Lymphoma
›
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted...
Tuesday, February 25, 2020
FDA Approves Brukinsa (zanubrutinib) for the Treatment of Mantle Cell Lymphoma
›
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing in...
›
Home
View web version
